Zobrazeno 1 - 10 of 1 047 pro vyhledávání: '"Rutten, I."'
1
Akademický článek
SeParate: multiway fluorescence-activated droplet sorting based on integration of serial and parallel triaging concepts.
Autor: Verbist W; Department of Biosystems - Biosensors Group, KU Leuven, Willem de Croylaan 42, Box 2428, 3001 Leuven, Belgium. jeroen.lammertyn@kuleuven.be., Breukers J; Department of Biosystems - Biosensors Group, KU Leuven, Willem de Croylaan 42, Box 2428, 3001 Leuven, Belgium. jeroen.lammertyn@kuleuven.be., Sharma S; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Molecular Vaccinology and Vaccine Discovery, KU Leuven, 3000 Leuven, Belgium., Rutten I; Department of Biosystems - Biosensors Group, KU Leuven, Willem de Croylaan 42, Box 2428, 3001 Leuven, Belgium. jeroen.lammertyn@kuleuven.be., Gerstmans H; Department of Biosystems - Biosensors Group, KU Leuven, Willem de Croylaan 42, Box 2428, 3001 Leuven, Belgium. jeroen.lammertyn@kuleuven.be., Coelmont L; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Molecular Vaccinology and Vaccine Discovery, KU Leuven, 3000 Leuven, Belgium., Dal Dosso F; Department of Biosystems - Biosensors Group, KU Leuven, Willem de Croylaan 42, Box 2428, 3001 Leuven, Belgium. jeroen.lammertyn@kuleuven.be., Dallmeier K; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Molecular Vaccinology and Vaccine Discovery, KU Leuven, 3000 Leuven, Belgium., Lammertyn J; Department of Biosystems - Biosensors Group, KU Leuven, Willem de Croylaan 42, Box 2428, 3001 Leuven, Belgium. jeroen.lammertyn@kuleuven.be.
Publikováno v: Lab on a chip [Lab Chip] 2024 Mar 26; Vol. 24 (7), pp. 2107-2121. Date of Electronic Publication: 2024 Mar 26.
Zobrazit plný text záznamu
2
Akademický článek
FLUIDOT: A Modular Microfluidic Platform for Single-Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining.
Autor: Breukers J; Department of Biosystems, Biosensors group, KU Leuven, Willem de Croylaan 42, Leuven, 3001, Belgium.; LISCO, KU Leuven Institute for Single Cell Omics, ON4 Herestraat 49, Leuven, 3000, Belgium., Ven K; Department of Biosystems, Biosensors group, KU Leuven, Willem de Croylaan 42, Leuven, 3001, Belgium.; LISCO, KU Leuven Institute for Single Cell Omics, ON4 Herestraat 49, Leuven, 3000, Belgium.; MabMine: KU Leuven Single B Cell Mining Platform, KU Leuven, ON2 Herestraat 49, 3000, Leuven, Belgium., Struyfs C; Centre of Microbial and Plant Genetics, KU Leuven, Kasteelpark Arenberg 20, Leuven, 3001, Belgium., Ampofo L; Department of Biosystems, Biosensors group, KU Leuven, Willem de Croylaan 42, Leuven, 3001, Belgium.; MabMine: KU Leuven Single B Cell Mining Platform, KU Leuven, ON2 Herestraat 49, 3000, Leuven, Belgium.; PharmAbs, The KU Leuven Antibody Center, KU Leuven, ON 2 Herestraat 49, Leuven, 3000, Belgium.; Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, ON2 Herestraat 49, Leuven, 3000, Belgium., Rutten I; Department of Biosystems, Biosensors group, KU Leuven, Willem de Croylaan 42, Leuven, 3001, Belgium.; LISCO, KU Leuven Institute for Single Cell Omics, ON4 Herestraat 49, Leuven, 3000, Belgium., Imbrechts M; MabMine: KU Leuven Single B Cell Mining Platform, KU Leuven, ON2 Herestraat 49, 3000, Leuven, Belgium.; PharmAbs, The KU Leuven Antibody Center, KU Leuven, ON 2 Herestraat 49, Leuven, 3000, Belgium.; Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, ON2 Herestraat 49, Leuven, 3000, Belgium., Pollet F; Department of Biosystems, Biosensors group, KU Leuven, Willem de Croylaan 42, Leuven, 3001, Belgium., Van Lent J; Department of Biosystems, Biosensors group, KU Leuven, Willem de Croylaan 42, Leuven, 3001, Belgium., Kerstens W; Translational Platform Virology and Chemotherapy, Rega Institute, KU Leuven, Rega - Herestraat 49, Leuven, 3000, Belgium., Noppen S; Laboratory of Virology and Chemotherapy, Rega Institute, KU Leuven, Rega - Herestraat 49, Leuven, 3000, Belgium., Schols D; Laboratory of Virology and Chemotherapy, Rega Institute, KU Leuven, Rega - Herestraat 49, Leuven, 3000, Belgium., De Munter P; Department of Internal Medicine, University Hospitals Leuven, UZ Herestraat 49, Leuven, 3000, Belgium.; Laboratory for Clinical Infectious and Inflammatory Disorders, KU Leuven, UZ Herestraat 49, Leuven, 3000, Belgium., Thibaut HJ; Translational Platform Virology and Chemotherapy, Rega Institute, KU Leuven, Rega - Herestraat 49, Leuven, 3000, Belgium., Vanhoorelbeke K; MabMine: KU Leuven Single B Cell Mining Platform, KU Leuven, ON2 Herestraat 49, 3000, Leuven, Belgium.; PharmAbs, The KU Leuven Antibody Center, KU Leuven, ON 2 Herestraat 49, Leuven, 3000, Belgium.; Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Etienne Sabbelaan 53, Kortrijk, 8500, Belgium., Spasic D; Department of Biosystems, Biosensors group, KU Leuven, Willem de Croylaan 42, Leuven, 3001, Belgium., Declerck P; MabMine: KU Leuven Single B Cell Mining Platform, KU Leuven, ON2 Herestraat 49, 3000, Leuven, Belgium.; PharmAbs, The KU Leuven Antibody Center, KU Leuven, ON 2 Herestraat 49, Leuven, 3000, Belgium.; Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, ON2 Herestraat 49, Leuven, 3000, Belgium., Cammue BPA; Centre of Microbial and Plant Genetics, KU Leuven, Kasteelpark Arenberg 20, Leuven, 3001, Belgium., Geukens N; MabMine: KU Leuven Single B Cell Mining Platform, KU Leuven, ON2 Herestraat 49, 3000, Leuven, Belgium.; PharmAbs, The KU Leuven Antibody Center, KU Leuven, ON 2 Herestraat 49, Leuven, 3000, Belgium.; Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, ON2 Herestraat 49, Leuven, 3000, Belgium., Thevissen K; Centre of Microbial and Plant Genetics, KU Leuven, Kasteelpark Arenberg 20, Leuven, 3001, Belgium., Lammertyn J; Department of Biosystems, Biosensors group, KU Leuven, Willem de Croylaan 42, Leuven, 3001, Belgium.; LISCO, KU Leuven Institute for Single Cell Omics, ON4 Herestraat 49, Leuven, 3000, Belgium.; MabMine: KU Leuven Single B Cell Mining Platform, KU Leuven, ON2 Herestraat 49, 3000, Leuven, Belgium.; LIMNI, KU Leuven Institute for Micro- and Nanoscale Integration, Celestijnenlaan 200F, Leuven, 3001, Belgium.
Publikováno v: Small methods [Small Methods] 2023 Mar; Vol. 7 (3), pp. e2201477. Date of Electronic Publication: 2023 Jan 15.
Zobrazit plný text záznamu
3
Akademický článek
Highly Sensitive Multiplex Detection of Molecular Biomarkers Using Hybridization Chain Reaction in an Encoded Particle Microfluidic Platform.
Autor: Rutten I; Department of Biosystems, Biosensors Group, KU Leuven, 3001 Leuven, Belgium., Daems D; Department of Biosystems, Biosensors Group, KU Leuven, 3001 Leuven, Belgium., Leirs K; Department of Biosystems, Biosensors Group, KU Leuven, 3001 Leuven, Belgium., Lammertyn J; Department of Biosystems, Biosensors Group, KU Leuven, 3001 Leuven, Belgium.
Publikováno v: Biosensors [Biosensors (Basel)] 2023 Jan 06; Vol. 13 (1). Date of Electronic Publication: 2023 Jan 06.
Zobrazit plný text záznamu
5
Akademický článek
Highly flexible and accurate serial picoinjection in droplets by combined pressure and flow rate control.
Autor: Breukers J; Department of Biosystems, Biosensors Group, KU Leuven, Leuven 3001, Belgium. jeroen.lammertyn@kuleuven.be., Op de Beeck H; Department of Biosystems, Biosensors Group, KU Leuven, Leuven 3001, Belgium. jeroen.lammertyn@kuleuven.be., Rutten I; Department of Biosystems, Biosensors Group, KU Leuven, Leuven 3001, Belgium. jeroen.lammertyn@kuleuven.be., López Fernández M; Confo Therapeutics, Technologiepark-Zwijnaarde 30, Ghent 9052, Belgium.; Center for Medical Biotechnology, VIB-Ghent University, Technologiepark-Zwijnaarde 75, Ghent 9052, Belgium.; Department of Biomolecular Medicine, Ghent University, Technologiepark-Zwijnaarde 75, Ghent 9052, Belgium., Eyckerman S; Center for Medical Biotechnology, VIB-Ghent University, Technologiepark-Zwijnaarde 75, Ghent 9052, Belgium.; Department of Biomolecular Medicine, Ghent University, Technologiepark-Zwijnaarde 75, Ghent 9052, Belgium., Lammertyn J; Department of Biosystems, Biosensors Group, KU Leuven, Leuven 3001, Belgium. jeroen.lammertyn@kuleuven.be.
Publikováno v: Lab on a chip [Lab Chip] 2022 Sep 13; Vol. 22 (18), pp. 3475-3488. Date of Electronic Publication: 2022 Sep 13.
Zobrazit plný text záznamu
7
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
Autor: Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, Van Den Weyngaert D, Kaendler S, Krauseneck P, Vinolas N, Villa S, Wurm RE, Maillot MHB, Spagnolli F, Kantor G, Malhaire JP, Renard L, De Witte O, Scandolaro L, Vecht CJ, Maingon P, Lutterbach J, Kobierska A, Bolla M, Souchon R, Mitine C, Tzuk-Shina T, Kuten A, Haferkamp G, de Greve J, Priou F, Menten J, Rutten I, Clavere P, Malmstrom A, Jancar B, Newlands E, Pigott K, Twijnstra A, Chinot O, Reni M, Boiardi A, Fabbro M, Campone M, Bozzino J, Frenay M, Gijtenbeek J, Delattre JY, De Paula U, Hanzen C, Pavanato G, Schraub S, Pfeffer R, Soffietti R, Kortmann RD, Taphoorn M, Torrecilla JL, Grisold W, Huget P, Forsyth P, Fulton D, Kirby S, Wong R, Fenton D, Cairncross G, Whitlock P, Burdette-Radoux S, Gertler S, Saunders S, Laing K, Siddiqui J, Martin LA, Gulavita S, Perry J, Mason W, Thiessen B, Pai H, Alam ZY, Eisenstat D, Mingrone W, Hofer S, Pesce G, Dietrich PY, Thum P, Baumert B, Ryan G
Publikováno v: New England Journal of Medicine, vol. 352, no. 10, pp. 987-96
New England Journal of Medicine, 352(10), 987-996. Massachussetts Medical Society
BACKGROUND: Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal. The current standard of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, followed by adjuvant radiotherapy. In this
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf112f90a929a68afabcd377cbf792ea
https://doi.org/10.1056/NEJMoa043330
Zobrazit plný text záznamu
8
Akademický článek
Cartilaginous spheroid-assembly design considerations for endochondral ossification: towards robotic-driven biomanufacturing.
Autor: Nilsson Hall G; Prometheus Division of Skeletal Tissue Engineering, KU Leuven, O&N1, Herestraat 49, PB 813, 3000 Leuven, Belgium.; Skeletal Biology and Engineering Research Center, Department of Development and Regeneration, KU Leuven, O&N1, Herestraat 49, PB 813, 3000 Leuven, Belgium., Rutten I; Department of Biosystems, Biosensors Group, KU Leuven, Willem de Croylaan 42, Box 2428, 3001 Leuven, Belgium., Lammertyn J; Department of Biosystems, Biosensors Group, KU Leuven, Willem de Croylaan 42, Box 2428, 3001 Leuven, Belgium., Eberhardt J; ALS Automated Lab Solutions GmbH, Jena, Germany., Geris L; Prometheus Division of Skeletal Tissue Engineering, KU Leuven, O&N1, Herestraat 49, PB 813, 3000 Leuven, Belgium.; GIGA in silico medicine, Université de Liège, Avenue de l'Hôpital 11-BAT 34, 4000 Liège 1, Belgium.; Biomechanics Section, KU Leuven, Celestijnenlaan 300C, PB 2419, 3001 Leuven, Belgium., Luyten FP; Prometheus Division of Skeletal Tissue Engineering, KU Leuven, O&N1, Herestraat 49, PB 813, 3000 Leuven, Belgium.; Skeletal Biology and Engineering Research Center, Department of Development and Regeneration, KU Leuven, O&N1, Herestraat 49, PB 813, 3000 Leuven, Belgium., Papantoniou I; Prometheus Division of Skeletal Tissue Engineering, KU Leuven, O&N1, Herestraat 49, PB 813, 3000 Leuven, Belgium.; Skeletal Biology and Engineering Research Center, Department of Development and Regeneration, KU Leuven, O&N1, Herestraat 49, PB 813, 3000 Leuven, Belgium.; Institute of Chemical Engineering Sciences, Foundation for Research and Technology-Hellas, Stadiou 26504, Platani, Patras, Greece.
Publikováno v: Biofabrication [Biofabrication] 2021 Sep 21; Vol. 13 (4). Date of Electronic Publication: 2021 Sep 21.
Zobrazit plný text záznamu
9
Akademický článek
From Initial Encounter With Mid-Air Haptic Feedback to Repeated Use: The Role of the Novelty Effect in User Experience.
Autor: Rutten I, Bogaert LVD, Geerts D
Publikováno v: IEEE transactions on haptics [IEEE Trans Haptics] 2021 Jul-Sep; Vol. 14 (3), pp. 591-602. Date of Electronic Publication: 2021 Sep 09.
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje